4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000899243-21-031104
Director bought 125,000 shares at $8.00 ($1,000,000)
- Director acquired 283,514 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Martell Christopher Director | 2021-07-29 | Conversion | +283,514 | 283,514 | I | ||
| Martell Christopher Director | 2021-07-29 | Purchase | +125,000 | $8.00 | $1,000,000 | 125,000 | I |
| Derivatives | |||||||
| Martell Christopher Director | 2021-07-29 | Conversion · Series B Preferred Stock | −696,851 | 0 | I | ||
| Open-market purchases · 125,000 sh · avg $8.00 · $1,000,000 | |||||||
Loading xslF345X03/doc4.xml…